2025 年 5 月 6 日 公司研究 格索雷塞片成功获批上市，期待 D-2570 更多数据读出 盈利预测、估值与评级：由于核心产品 D-0120 启动美国临床试验，D-2570 新 增针对溃疡性结肠炎、克罗恩病等多个适应症的临床开发，预计将导致研发费用 大幅度增加，我们下调 2025~2026 年归母净利润预测为-2.57/ -2.23 亿元（原预 测为-1.91/-1.50 亿元），新增 2027 年归母净利润预测为-0.46 亿元。考虑到公 司技术平台潜力巨大，布局思路领先，维持"买入"评级。 风险提示：研发进度不达预期风险；政策变化带来价格下降风险；竞争加剧风险。 公司盈利预测与估值简表 ——益方生物-U（688382.SH）2024 年年报点评 要点 事件：公司发布 2024 年年报，实现营业收入 1.69 亿元，同比下降 9.02%；归 母净利润为-2.40 亿元；扣非归母净利润为-2.50 亿元；经营活动产生的现金流量 净额为-2.42 亿元。 点评： 全力推进临床研究，格索雷塞片成功获批上市。 2024 年公司全力推进主要产 品的临床研究，并取得了重要进展。2024 年 11 月，格索雷塞片获 ...

Investment Rating - The report maintains a "Buy" rating for Tianrun Dairy (600419.SH) [6] Core Views - Tianrun Dairy's 2024 annual revenue reached 2.804 billion yuan, a year-on-year increase of 3.33%, while the net profit attributable to shareholders dropped by 69.26% to 43.66 million yuan [1] - The company faced challenges in the first quarter of 2025, with a revenue of 625 million yuan, a decrease of 2.50% year-on-year, and a net loss of 73.30 million yuan [1][4] - The report highlights the impact of cattle impairment on short-term profits, with a projected recovery in profitability expected as the company normalizes its cattle culling rate [3][4] Summary by Sections Financial Performance - In 2024, Tianrun Dairy's revenue was 2.804 billion yuan, with a net profit of 43.66 million yuan, and a significant decline in net profit margin to 1.56% [1][3] - The first quarter of 2025 showed a revenue of 625 million yuan, with a net loss of 73.30 million yuan, indicating a challenging market environment [1][4] Product Categories - The revenue breakdown for Q1 2025 showed that the revenue from ambient dairy products, low-temperature dairy products, and livestock products were 347 million yuan, 239 million yuan, and 17 million yuan respectively, with low-temperature products being relatively stable [2] Profitability and Costs - The gross margin for 2024 was 16.76%, with a decline in Q1 2025 to 14.63% due to increased promotional activities [3] - Selling expense ratio increased to 6.87% in Q1 2025, attributed to promotional discounts [3] Profit Forecast and Valuation - The net profit forecasts for 2025 and 2026 have been revised down to 108 million yuan and 195 million yuan, respectively, with an introduction of a 2027 forecast of 247 million yuan [4] - The report indicates that the current stock price corresponds to a P/E ratio of 29x for 2025, 16x for 2026, and 13x for 2027, reflecting the company's differentiated product advantages and growth potential in external markets [4]

2025 年 5 月 6 日 公司研究 低温业务增势良好，盈利能力持续提升 ——新乳业（002946.SZ）2024 年报及 2025 年一季报点评 要点 事件：新乳业发布 2024 年年报和 2025 年一季报，2024 全年实现营业收入 106.65 亿元，同比-2.93%；归母净利润 5.38 亿元，同比+24.80%；扣非归母净 利润 5.79 亿元，同比+24.47%。其中，24Q4 单季度实现营业收入 25.16 亿元， 同比-9.94%；归母净利润 0.64 亿元，同比+28.08%；扣非归母净利润 0.72 亿元， 同比-2.25%。25Q1 实现营业收入 26.25 亿元，同比+0.42%；归母净利润 1.33 亿元，同比+48.46%；扣非归母净利润 1.41 亿元，同比+40.35%。 低温品类持续向好，电商渠道增长积极。1）分产品看，2024 年液态奶/奶粉/ 其他产品分别实现营收 98.36/0.71/7.58 亿元，同比+0.83%/-9.63%/ -34.27%。 其中低温鲜奶和低温酸奶收入同比实现中高个位数增长，高端鲜奶及低温调制乳 品类收入同比实现双位数增长。公司持续推进新品 ...

2025 年 5 月 6 日 公司研究 控费提质驱动净利扭亏，"安全为基，智算为擎，信创为锚"助公司发展 ——天融信（002212.SZ）2024 年年报点评 要点 事件：公司发布 2024 年年度报告，2024 年公司实现营收 28.20 亿元，同比减 少 9.73%；实现归母净利润 0.83 亿元，同比扭亏。Q424 公司实现营收 12.38 亿元，同比下降 16.15%；实现归母净利润 2.52 亿元，同比扭亏。 云计算构筑第二增长曲线。分产品看，2024 年，公司云计算业务实现收入 2.56 亿元，同比增长 10.09%；网络安全业务实现收入 25.50 亿元，同比减少 11.49%。 分客户所在行业看，2024 年，公司政府及事业单位客户实现收入 12.76 亿元， 同比减少 10.58%；国有企业客户实现收入 8.65 亿元，同比减少 3.34%。 毛利率连续三年增长，控费提质效果明显。公司 2024 年毛利率同比增长 0.85 个百分点，由 2022 年的 59.72%提升至 2024 年的 61.04%。公司持续积极应对 行业和市场发展态势，深化实施增效提质战略。2024 年营销、研发、管理三 ...

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company achieved a revenue of 1.659 billion yuan in 2024, representing a year-on-year increase of 17.56%, and a net profit of 182 million yuan, recovering from a net loss of 11 million yuan in the same period last year [1] - The domestic market shows strong growth in self-owned brands, while the agency business continues to shrink, leading to a decline in domestic revenue [2] - The gross margin improved in 2024, but profitability faced pressure due to increased marketing expenses related to the New Zealand grain project [3] - The company is adjusting its profit forecasts for 2025-2026 due to uncertainties related to tariff impacts, projecting net profits of 200 million yuan and 240 million yuan respectively [4] Summary by Sections Financial Performance - In 2024, the company reported total revenue of 1.659 billion yuan, with a significant increase in self-owned brand revenue, while agency brand revenue declined [2] - The gross margin for 2024 was 29.42%, with a notable improvement in the first quarter of 2025 [3] - The net profit for 2024 was 182 million yuan, a recovery from the previous year's loss, with projections for future profits adjusted downwards [4] Market Dynamics - The domestic market is performing well for self-owned brands, while the agency business is contracting, impacting overall revenue [2] - The company is diversifying its overseas revenue sources to mitigate tariff impacts, particularly in the context of its operations in Vietnam and Cambodia [2] Profitability and Cost Management - The gross margin for 2024 was 29.42%, with a year-on-year increase in the first quarter of 2025 attributed to improved margins in self-owned brands [3] - Marketing expenses increased due to the upcoming large-scale production of the New Zealand grain project, affecting overall profitability [3] Future Outlook - The company has revised its profit forecasts for 2025 and 2026, now expecting net profits of 200 million yuan and 240 million yuan, respectively, due to tariff uncertainties [4] - The projected earnings per share (EPS) for 2025 is 0.80 yuan, with a price-to-earnings (P/E) ratio of 19 [5]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has experienced rapid revenue growth in the 3C and passenger vehicle sectors, driven by new coating solutions [6][8] - The company reported a revenue of 746 million yuan in 2024, a year-on-year increase of 26.41%, and a net profit attributable to shareholders of 86.4 million yuan, up 6.52% year-on-year [5] - The company is focusing on high-end consumer electronics and passenger vehicle markets, with significant partnerships with major clients [6][7] Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 746 million yuan, with a net profit of 86.4 million yuan, and a quarterly revenue of 2.19 billion yuan in Q4 2024, reflecting a 25.23% year-on-year growth [5] - For Q1 2025, the company reported a revenue of 1.53 billion yuan, a 13.24% year-on-year increase, but a net profit of 381 thousand yuan, down 68.52% year-on-year [5][6] Revenue Growth Drivers - The 3C sector saw a revenue increase of 26.9% in 2024, attributed to deepened cooperation with North American clients and expanded product offerings [6] - The passenger vehicle sector achieved a revenue of 1.28 billion yuan in 2024, a 29.6% increase, with Q4 2024 showing a 51.6% year-on-year growth [6] Strategic Initiatives - The company is advancing new coating solutions and has successfully launched a new molecular coating material solution [7] - The company is also expanding into strategic emerging fields such as aerospace, with ongoing collaborations and product development [7] Profitability and Valuation - The report projects net profits of 127 million yuan for 2025, down from a previous estimate of 154 million yuan, with continued growth expected in the 3C and passenger vehicle sectors [8][9] - The company’s gross margin is expected to decline to 48.9% in 2025, with an increase in operating expenses impacting profitability [12]

2025 年 5 月 6 日 公司研究 经营稳健，新能源业务快速增长 ——中国能源建设（3996.HK）2024 年年报及 2025 年一季报点评 买入（维持） 当前价：0.98 港元 作者 执业证书编号：S0930523100001 021-52523879 wuyujie@ebscn.com 市场数据 | 总股本(亿股) | 416.91 | | --- | --- | | 总市值(港元)： | 859.45 | | 一年最低/最高(港元)： | 0.90/1.10 | | 近 3 月换手率： | 34.40% | 股价相对走势 -10% -2% 6% 14% 22% 10/22 01/23 04/23 07/23 中国能建 沪深300 | 收益表现 | | | | | --- | --- | --- | --- | | % | 1M | 3M | 1Y | | 相对 | -3.66 | -0.25 | -1.73 | | 绝对 | 1.38 | -0.90 | 1.35 | | 资料来源：Wind | | | | 要点 事件：公司发布 24 年年报及 25 年一季报, 24 年公司实现营业收入/归母净利 ...

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of China Railway (601390.SH/0390.HK) with current prices at 5.52 CNY and 3.38 HKD respectively [1]. Core Views - The company is experiencing operational pressure, with a significant decline in revenue and net profit for 2024, but new emerging businesses are growing rapidly [1][5]. - The company aims to improve cash flow and plans to increase mid-term dividends in 2025 [7][8]. Financial Performance - For 2024, the company reported operating revenue of 115.74 billion CNY, a decrease of 8.2% year-on-year, and a net profit attributable to shareholders of 27.89 billion CNY, down 16.7% [4][5]. - In Q1 2025, the company achieved operating revenue of 24.86 billion CNY, a decline of 6.2% year-on-year, with net profit down 19.5% [4][5]. Business Segments - The main business segments, including infrastructure, design consulting, equipment manufacturing, real estate development, and resource utilization, saw revenue declines ranging from 2.5% to 13.1% in 2024 [5]. - The company’s overseas business revenue increased by 10.3% while domestic revenue decreased by 9.1% [5][6]. Emerging Business Growth - New contracts signed in 2024 totaled 2715.18 billion CNY, a decrease of 12.4% year-on-year, with domestic contracts down 14.0% and international contracts up 10.6% [6]. - Emerging business contracts grew by 11.3%, particularly in water conservancy and clean energy sectors, which saw increases of 50% and 22.6% respectively [6]. Cost Management and Dividends - The company effectively managed overall expenses in 2024, despite increased financial costs due to delayed payments from project owners [7]. - A proposed dividend of 1.78 CNY per 10 shares for 2024 reflects a payout ratio of 15.79%, an increase of 0.27 percentage points from the previous year [7]. Profit Forecast and Valuation - The profit forecast for 2025 and 2026 has been adjusted downwards, with net profit estimates of 28.22 billion CNY and 28.64 billion CNY respectively, reflecting a decrease of 10% and 13% [8]. - The report maintains a "Buy" rating based on the rapid growth of emerging industries and overseas orders [8].

2025 年 5 月 6 日 ——东方铁塔（002545.SZ）2024 年报及 2025 一季报点评 增持（维持） 分析师：周家诺 公司研究 执业证书编号：S0930523070007 021-52523675 zhoujianuo@ebscn.com 24 年氯化钾产销量显著提升，积极推进第二个百万吨项目建设 市场数据 当前价：7.62 元 作者 分析师：赵乃迪 执业证书编号：S0930517050005 010-57378026 zhaond@ebscn.com | 总股本(亿股) | 12.44 | | --- | --- | | 总市值(亿元)： | 94.80 | | 一年最低/最高(元)： | 5.66/8.48 | | 近 3 月换手率： | 91.10% | 股价相对走势 -17% -8% 2% 12% 21% 04/24 07/24 10/24 01/25 东方铁塔 沪深300 收益表现 | % | 1M | 3M | 1Y | | --- | --- | --- | --- | | 相对 | 6.03 | 9.66 | -2.89 | | 绝对 | 11.08 | 9.01 | 0.19 ...

2025 年 5 月 6 日 公司研究 25Q1 扭亏为盈，行业景气回升可期 ——安道麦 A（000553.SZ）2025 一季报点评 要点 事件：公司发布 2025 年一季报。2025Q1，公司单季度实现营收 71.73 亿元， 同比减少 4.48%，环比减少 9.94%；实现归母净利润 1.51 亿元，同环比均扭亏 为盈；实现扣非后归母净利润 1.02 亿元，同环比均扭亏为盈。 点评： 毛利率及现金流显著改善，25Q1 扭亏为盈。2025Q1，公司销量同比基本持平， 销售均价（以美元计）同比下降 4%。得益于前期高价库存的持续性消化，25Q1 公司新售出存货成本降低，从而使得公司整体毛利率显著改善。按人民币计， 25Q1 公司毛利率同比提升 2.9pct 至 27.2%。费用率方面，除管理费用率外， 25Q1 公司销售、研发、财务费用率均有所降低。由于"奋进"转型计划的推进， 公司相关的重组与咨询成本增加，导致管理费用率同比提升 1.5pct 至 5.2%。 25Q1，公司销售、研发、财务费用率同比分别下降 1.1pct、0.04pct、4.6pct。 现金流方面，25Q1 公司经营活动产生的现金流量净额 ...